Works matching IS 01676997 AND DT 2019 AND VI 37 AND IP 6

Results: 22

Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway.

Published in:

2019

By:

Zhao, Piming;
Aguilar, Ana E.;
Lee, Joanna Y.;
Paul, Lucy A.;
Suh, Jung H.;
Puri, Latika;
Zhang, Meng;
Beckstead, Jennifer;
Witkowski, Andrzej;
Ryan, Robert O.;
Saba, Julie D.

Publication type:

Correction Notice

Correction to: Inhibitory effects of tea polyphenols by targeting cyclooxygenase-2 through regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumors.

Published in:

2019

By:

Roy, Preeti;
George, Jasmine;
Srivastava, Smita;
Tyagi, Shilpa;
Shukla, Yogeshwer

Publication type:

Correction Notice

A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1247, doi. 10.1007/s10637-019-00825-0

By:

Capriotti, Kara D.;
Anadkat, Milan;
Choi, Jennifer;
Kaffenberger, Benjamin;
McLellan, Beth;
Barone, Samuel;
Kukoyi, Oluwaseun;
Goldfarb, Shari;
Lacouture, Mario

Publication type:

Article

A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1239, doi. 10.1007/s10637-019-00817-0

By:

Park, Inkeun;
Lee, Hyo Jin;
Bae, Woo Kyoon;
Yoon, Shinkyo;
Lee, Jae Lyun

Publication type:

Article

Early depth of tumor shrinkage and treatment outcomes in non-small cell lung cancer treated using Nivolumab.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1257, doi. 10.1007/s10637-019-00770-y

By:

Kawachi, Hayato;
Fujimoto, Daichi;
Morimoto, Takeshi;
Hosoya, Kazutaka;
Sato, Yuki;
Kogo, Mariko;
Nagata, Kazuma;
Nakagawa, Atsushi;
Tachikawa, Ryo;
Tomii, Keisuke

Publication type:

Article

Efficacy and safety of pembrolizumab as first-line therapy in advanced non-small cell lung cancer with at least 50% PD-L1 positivity: a multicenter retrospective cohort study (HOPE-001).

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1266, doi. 10.1007/s10637-019-00843-y

By:

Tamiya, Motohiro;
Tamiya, Akihiro;
Hosoya, Kazutaka;
Taniguchi, Yoshihiko;
Yokoyama, Toshihide;
Fukuda, Yasushi;
Hirano, Katsuya;
Matsumoto, Hirotaka;
Kominami, Ryota;
Suzuki, Hidekazu;
Hirashima, Tomonori;
Uchida, Junji;
Morita, Mitsunori;
Kanazu, Masaki;
Sawa, Nobuhiko;
Kinoshita, Yoshinori;
Hara, Satoshi;
Kumagai, Toru;
Fujimoto, Daichi

Publication type:

Article

Discovery and anticancer evaluation of a formononetin derivative against gastric cancer SGC7901 cells.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1300, doi. 10.1007/s10637-019-00767-7

By:

Yao, Jian-Ning;
Zhang, Xue-Xiu;
Zhang, Yan-Zhen;
Li, Jia-Heng;
Zhao, Dong-Yao;
Gao, Bing;
Zhou, Hai-Ning;
Gao, Shi-Lin;
Zhang, Lian-Feng

Publication type:

Article

Cellular uptake evaluation of pentagamaboronon-0 (PGB-0) for boron neutron capture therapy (BNCT) against breast cancer cells.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1292, doi. 10.1007/s10637-019-00765-9

By:

Hermawan, Adam;
Susidarti, Ratna Asmah;
Ramadani, Ratna Dwi;
Qodria, Lailatul;
Utomo, Rohmad Yudi;
Ishimura, Miki;
Hattori, Yoshihide;
Ohta, Yoichiro;
Kirihata, Mitsunori;
Meiyanto, Edy

Publication type:

Article

Ramucirumab as a second line therapy for advanced HCC: a significant achievement or a wasted opportunity for personalised therapy?

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1274, doi. 10.1007/s10637-019-00760-0

By:

Roviello, Giandomenico;
Sohbani, Navid;
Petrioli, Roberto;
Rodriquenz, Maria Grazia

Publication type:

Article

Novel palladium (II) complexes with tetradentate thiosemicarbazones. Synthesis, characterization, in vitro cytotoxicity and xanthine oxidase inhibition.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1187, doi. 10.1007/s10637-019-00751-1

By:

Özerkan, Dilşad;
Ertik, Onur;
Kaya, Buşra;
Kuruca, Serap Erdem;
Yanardag, Refiye;
Ülküseven, Bahri

Publication type:

Article

A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1166, doi. 10.1007/s10637-019-00750-2

By:

Liu, Xiaoli;
Wang, Wei;
Yin, Yanping;
Li, Ming;
Li, Hong;
Xiang, Hang;
Xu, Ao;
Mei, Xiaodong;
Hong, Bo;
Lin, Wenchu

Publication type:

Article

Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasion.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1177, doi. 10.1007/s10637-019-00748-w

By:

Miao, Fa-an;
Chu, Kun;
Chen, Hai-rong;
Zhang, Meng;
Shi, Pei-cong;
Bai, Jin;
You, Yong-ping

Publication type:

Article

Population pharmacokinetic analysis of AR-67, a lactone stable camptothecin analogue, in cancer patients with solid tumors.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1218, doi. 10.1007/s10637-019-00744-0

By:

Tang, Fei;
Tsakalozou, Eleftheria;
Arnold, Susanne M.;
Ng, Chee M.;
Leggas, Markos

Publication type:

Article

A phthalimidoalkanamide derived novel DNMT inhibitor enhanced radiosensitivity of A549 cells by inhibition of homologous recombination of DNA damage.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1158, doi. 10.1007/s10637-019-00730-6

By:

Kang, Hyun-Cheol;
Chie, Eui Kyu;
Kim, Hak Jae;
Kim, Jin Ho;
Kim, Il Han;
Kim, Kwangsoo;
Shin, Beom Su;
Ma, EunSook

Publication type:

Article

LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/ FOXP1 axis in lung cancer.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1127, doi. 10.1007/s10637-018-00721-z

By:

Wang, Ansheng;
Zhao, Chengling;
Gao, Yuan;
Duan, Guixin;
Yang, Yuming;
Fan, Bo;
Wang, Xiaojing;
Wang, Kangwu

Publication type:

Article

Axitinib pharmacologic therapeutic monitoring reveals severe under-exposure despite titration in patients with metastatic renal cell carcinoma.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1289, doi. 10.1007/s10637-019-00743-1

By:

Beinse, G.;
Hulin, A.;
Rousseau, Benoit

Publication type:

Article

Delineation of proapoptotic signaling of anthracene-shelled M<sub>2</sub>L<sub>4</sub> metallacapsules and their synergistic activity with curcumin in cisplatin-sensitive and resistant tumor cell lines.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1117, doi. 10.1007/s10637-019-00738-y

By:

Mihaylova, Rositsa;
Ahmedova, Anife;
Momekova, Denitsa;
Momekov, Georgi;
Danchev, Nikolay

Publication type:

Article

Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1198, doi. 10.1007/s10637-019-00736-0

By:

Martini, Dylan J.;
Liu, Yuan;
Shabto, Julie M.;
Lewis, Colleen;
Kline, Meredith R.;
Collins, Hannah;
Akce, Mehmet;
Kissick, Haydn T.;
Carthon, Bradley C.;
Shaib, Walid L.;
Alese, Olatunji B.;
Pillai, Rathi N.;
Steuer, Conor E.;
Wu, Christina S.;
Lawson, David H.;
Kudchadkar, Ragini R.;
Master, Viraj A.;
El-Rayes, Bassel F.;
Ramalingam, Suresh S.;
Owonikoko, Taofeek K.

Publication type:

Article

Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1207, doi. 10.1007/s10637-019-00732-4

By:

Nishio, Makoto;
Murakami, Haruyasu;
Ohe, Yuichiro;
Hida, Toyoaki;
Sakai, Hiroshi;
Kasahara, Kazuo;
Imamura, Fumio;
Baba, Tomohisa;
Kubota, Kaoru;
Hosomi, Yukio;
Shimokawa, Tsuneo;
Hayashi, Hidetoshi;
Miyadera, Kazutaka;
Tamura, Tomohide

Publication type:

Article

GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1135, doi. 10.1007/s10637-019-00741-3

By:

Brun, Sonia;
Bassissi, Firas;
Serdjebi, Cindy;
Novello, Marie;
Tracz, Jennifer;
Autelitano, François;
Guillemot, Marie;
Fabre, Philippe;
Courcambeck, Jérôme;
Ansaldi, Christelle;
Raymond, Eric;
Halfon, Philipe

Publication type:

Article

Synergistic effect and reduced toxicity by intratumoral injection of cytarabine-loaded hyaluronic acid hydrogel conjugates combined with radiotherapy on lung cancer.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1146, doi. 10.1007/s10637-019-00740-4

By:

Tang, Juan;
Wang, Na;
Wu, JingBo;
Ren, PeiRong;
Li, JunYang;
Yang, LiShi;
Shi, XiangXiang;
Chen, Yue;
Fu, ShaoZhi;
Lin, Sheng

Publication type:

Article

Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer.

Published in:

Investigational New Drugs, 2019, v. 37, n. 6, p. 1231, doi. 10.1007/s10637-018-00716-w

By:

Zahoor, Haris;
Mir, Maria C.;
Barata, Pedro C.;
Stephenson, Andrew J.;
Campbell, Steven C.;
Fergany, Amr;
Dreicer, Robert;
Garcia, Jorge A.

Publication type:

Article